Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | NWL | Common Stock | 13.7K | May 15, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | NWL | Restricted Stock Units | May 15, 2023 | Common Stock | 4.98K | Direct | F1, F2 | |||||||
holding | NWL | Restricted Stock Units | May 15, 2023 | Commonn Stock | 3.98K | $0.00 | Direct | F2, F3 | ||||||
holding | NWL | Restricted Stock Units | May 15, 2023 | Common Stock | 23.8K | $0.00 | Direct | F2, F4 | ||||||
holding | NWL | Stock Option (Right to Buy) | May 15, 2023 | Common Stock | 27.5K | $20.02 | Direct | F5 | ||||||
holding | NWL | Stock Option (Right to Buy) | May 15, 2023 | Common Stock | 37.3K | $23.79 | Direct | F6 | ||||||
holding | NWL | Stock Option (Right to Buy) | May 15, 2023 | Common Stock | 29.9K | $25.86 | Direct | F7 |
Id | Content |
---|---|
F1 | Each of the restricted stock units (RSUs) represents a contingent right to one share of the Company's common stock. The RSUs vest on February 16, 2024, subject to the Reporting Person's continued employment with the Company. |
F2 | N/A |
F3 | Each of the restricted stock units (RSUs) represents a contingent right to one share of the Company's common stock. The RSUs vest on February 18, 2025, subject to the Reporting Person's continued employment with the Company. |
F4 | Each of the RSUs represents a contingent right to one share of the Company's common stock. The RSUs vest ratably in one-third increments on first, second and third anniversary of the February 17, 2023 grant date, in each case subject to the Reporting Person's continued employment with the Company. |
F5 | The stock option grant vested ratably in one-third increments on the first, second and third anniversaries of the February 18, 2020 grant date based on continuous employment with the Company. |
F6 | The option became exercisable as to 12,447 shares on February 16, 2022, as to 12,448 shares on February 16, 2023, and will become exercisable as to 12,448 shares on February 16, 2024, subject to the Reporting Person's continuous employment with the Company. |
F7 | The option became exercisable as to 9,957 shares on February 18, 2023, and will become exercisable as to 9,957 shares and as to 9,958 shares on February 18, 2024 and February 18, 2025, respectively, in each case subject to the Reporting Person's continuous employment with the Company. |